UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
CNS drugs, ISSN 1172-7047, 2005, Volume 19, Issue 1, pp. 1 - 93
Journal Article
The journal of clinical psychiatry, ISSN 0160-6689, 2007, Volume 68, Issue 1, pp. 20 - 27
Journal Article
The journal of clinical psychiatry, ISSN 0160-6689, 2007, Volume 68, Issue 4, pp. 8 - 13
Obesity - chemically induced | Risk Assessment | Diabetes Mellitus - physiopathology | Insulin Resistance - physiology | Antipsychotic Agents - adverse effects | Humans | Diabetes Mellitus - chemically induced | Obesity - physiopathology | Schizophrenia - complications | Schizophrenia - drug therapy | Index Medicus
Journal Article
CNS drugs, ISSN 1172-7047, 12/2005, Volume 19, Issue S1, pp. 1 - 93
Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Obesity | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Neuropharmacology | Endocrine pancreas. Apud cells (diseases) | Metabolic Diseases - classification | Psychotic Disorders - complications | Antipsychotic Agents - adverse effects | Humans | Drug Evaluation | Metabolic Diseases - drug therapy | Risk | Clinical Trials as Topic | Animals | Hyperglycemia - chemically induced | Antipsychotic Agents - therapeutic use | Hyperlipidemias - etiology | Psychotic Disorders - drug therapy | Metabolic Diseases - complications | Index Medicus
Journal Article
Journal of psychiatric research, ISSN 0022-3956, 1999, Volume 33, Issue 6, pp. 523 - 533
Psychosis | Prevention | Rat model | Treatment | Neurodegeneration | Schizophrenia | NMDA receptors | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychology. Psychoanalysis. Psychiatry | Psychoses | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Phencyclidine - pharmacology | Schizophrenia - therapy | Animals | Models, Biological | Schizophrenia - physiopathology | Humans | Enzyme Inhibitors - pharmacology | Models, Psychological | Rats | Receptors, N-Methyl-D-Aspartate - physiology | Disease Models, Animal | Schizophrenia - etiology | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2007, Volume 298, Issue 15, pp. 1794 - 1796
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - complications | Mental Disorders - epidemiology | Delivery of Health Care | Life Expectancy | United States | Cardiovascular Diseases - prevention & control | Humans | Cardiovascular Diseases - epidemiology | Mental Disorders - complications | Risk | Needs Assessment | Disease prevention | Cardiovascular disease | Mental disorders | Personal health | Mortality
Journal Article
Diabetes care, ISSN 0149-5992, 06/2009, Volume 32, Issue 6, pp. 1037 - 1042
Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Antidepressive Agents, Second-Generation - adverse effects | Mental Disorders - blood | United States | Humans | Middle Aged | Risk Factors | Male | Mental Health | Antidepressive Agents, Second-Generation - therapeutic use | Consensus Development Conferences as Topic | Blood Glucose - drug effects | Societies, Medical | Mental Disorders - drug therapy | Substance-Related Disorders - epidemiology | Lipids - blood | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Diabetes Complications - epidemiology | Adult | Female | Aged | Blood Glucose - metabolism | Cohort Studies | Drugs | Diabetics | Medical research | Antipsychotic drugs | Medicine, Experimental | Research | Diabetes | Glucose | Pharmaceutical industry | Dextrose | Diseases | Diabetes therapy | Mortality | Schizophrenia | Cardiovascular disease | Metabolic syndrome | Medical screening | Patients | Risk factors | Psychotropic drugs | Mental health care | Hyperglycemia | Illnesses | Clinical medicine | Medicaid | Personality disorders | Index Medicus | Original Research
Journal Article
The journal of clinical psychiatry, ISSN 0160-6689, 2006, Volume 67, Issue 9, pp. 25 - 30
Life Style | Prevalence | Comorbidity | Antipsychotic Agents - adverse effects | Humans | Risk Factors | Anticonvulsants - therapeutic use | Metabolic Syndrome - chemically induced | Bipolar Disorder - drug therapy | Schizophrenia - epidemiology | Lithium - therapeutic use | Anticonvulsants - adverse effects | Antipsychotic Agents - therapeutic use | Lithium - adverse effects | Cardiovascular Diseases - epidemiology | Schizophrenia - drug therapy | Cognition Disorders - epidemiology | Bipolar Disorder - epidemiology | Metabolic Syndrome - epidemiology | Index Medicus
Journal Article
World psychiatry, ISSN 1723-8617, 06/2011, Volume 10, Issue 2, pp. 138 - 151
INDUCED HYPERPROLACTINEMIA | SMOKING-CESSATION | METABOLIC SYNDROME | monitoring and treatment guidelines | severe mental illness | 2ND-GENERATION ANTIPSYCHOTIC MEDICATIONS | UMCG Approved | ATYPICAL ANTIPSYCHOTICS | barriers | health disparities | physical health | CARDIOVASCULAR-DISEASE | Physical illness | PSYCHIATRIC-DISORDERS | PLACEBO-CONTROLLED TRIAL | INDUCED WEIGHT-GAIN | HEALTH-CARE | health care | Health care | Severe mental illness | Barriers | Physical health | Monitoring and treatment guidelines | Health disparities | Life Sciences & Biomedicine | Psychiatry | Science & Technology | WPA Educational Module
Journal Article